Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.60 |
| ▸ | GSDMD | P57764 | 2/20 | 0.60 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 7/20 | 0.57 |
| ▸ | CA2 | P00918 | 7/20 | 0.57 |
| ▸ | CA9 | Q16790 | 7/20 | 0.57 |
| ▸ | CA1 | P00915 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2233780 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Water SCHEMBL27918103 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Ammonia Solution, Strong SCHEMBL6300194 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Hydrogen Sulfide SCHEMBL7978771 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Selenium SCHEMBL11490632 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Ammonia Solution, Strong SCHEMBL9323211 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| SCHEMBL27926635 | 0.97 | HTT (0.57) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Zinc Ion SCHEMBL2986374 | 0.95 | ABCB11 (0.55) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Ethylene SCHEMBL21221525 | 0.95 | ABCB11 (0.55) | HTTABCB11GSDMDCYP2E1PTGS1 | |
| Water SCHEMBL27426640 | 0.95 | ABCB11 (0.55) | HTTABCB11GSDMDCYP2E1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250207021-A1 | QUANTUM DOT AND PREPARATION METHOD THEREOF, AND LIGHT-EMITTING DEVICE | GUANGDONG JUHUA RESEARCH INSTITUTE OF ADVANCED DISPLAY (CN) | 2025-06-26 | — | — | US | claimed |
| CN-114014277-B | Copper indium selenium nanocrystal, nano film, preparation method of copper indium selenium nanocrystal and preparation method of nano film and electronic device | 广东省科学院半导体研究所 | 2023-04-11 | — | — | CN | claimed |
| US-20230100631-A1 | Nonaqueous Electrolyte Solution and Lithium Secondary Battery Comprising the Same | LG ENERGY SOLUTION, LTD. (KR) | 2023-03-30 | — | — | US | claimed |
| CN-114014277-A | Copper indium selenium nanocrystal, nano film, preparation method of copper indium selenium nanocrystal and preparation method of nano film and electronic device | 广东省科学院半导体研究所 | 2022-02-08 | — | — | CN | claimed |
| CN-113430375-A | Method for separating low-valence ferrovanadium-chromium solution | 四川大学 | 2021-09-24 | — | — | CN | claimed |
| CN-112074332-A | Method and system for supercritical fluid extraction of metals | 多伦多大学管理委员会 | 2020-12-11 | — | — | CN | claimed |
| US-20190328886-A1 | COMPOSITIONS COMPRISING A METAL SOURCE, DITHIOCARBAMATE AND CYCLODEXTRIN | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2019-10-31 | — | — | US | claimed |
| EP-3525886-A1 | COMPOSITIONS COMPRISING A METAL SOURCE, DITHIOCARBAMATE AND CYCLODEXTRIN | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts (DE) | 2019-08-21 | — | — | EP | claimed |
| WO-2018069525-A1 | COMPOSITIONS COMPRISING A METAL SOURCE, DITHIOCARBAMATE AND CYCLODEXTRIN | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2018-04-19 | — | — | WO | claimed |
| EP-1688407-B1 | METHOD OF PURIFYING (METH)ACRYLIC ACID | MITSUBISHI CHEM CORP (JP) | 2017-01-25 | — | — | EP | claimed |
| US-20040018147-A1 | Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2004-01-29 | — | — | US | claimed |
| EP-1307239-A1 | RADIOPHARMACEUTICAL FOR DIAGNOSTIC IMAGING CONTAINING A TECHNETIUM-99M NITRIDE HETEROCOMPLEX | Nihon Medi-Physics Co., Ltd. (JP) | 2003-05-07 | — | — | EP | claimed |
| CN-1407854-A | N-aryi-uracile-based herbicides | BAYER AG (DE) | 2003-04-02 | — | — | CN | claimed |
| WO-2002009771-A1 | RADIOPHARMACEUTICAL FOR DIAGNOSTIC IMAGING CONTAINING A TECHNETIUM-99M NITRIDE HETEROCOMPLEX | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-02-07 | — | — | WO | claimed |
| EP-0690091-B1 | Improvements in and relating to the reclaiming of natural and synthetic rubbers | SEKHAR B C SDN BHD (MY) | 1999-09-15 | — | — | EP | claimed |
| EP-0485213-B1 | Aquatic antifouling compositions | ROHM & HAAS (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0485213-A1 | Aquatic antifouling compositions | ROHM AND HAAS COMPANY (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0475781-A1 | Aquatic antifouling compositions | ROHM AND HAAS COMPANY (US) | 1992-03-18 | — | — | EP | claimed |
| EP-0208541-B1 | LUBRICANT COMPOSITIONS | NIPPON OIL CO. LTD. (JP) | 1991-12-04 | — | — | EP | claimed |
| EP-0010178-B1 | HERBICIDAL COMPOSITIONS WHICH CONTAIN A THIOCARBAMATE AND AN ORGANOPHOSPHOROUS COMPOUND AND THEIR APPLICATION | STAUFFER CHEMICAL COMPANY (US) | 1983-02-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190328886-A1 | COMPOSITIONS COMPRISING A METAL SOURCE, DITHIOCARBAMATE AND CYCLODEXTRIN | PDIA5, SLC30A5, SLC30A6 | HTT 1295/4885ABCB11 211/4885GSDMD 859/4885 |
| US-20040018147-A1 | Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex | SHBG, TNNT2, TNNI3 | HTT 3100/4885ABCB11 985/4885GSDMD 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.